"Shortage of Diclac tablets reported as demand increases unexpectedly"
"GPs are reporting a shortage of a widely used painkiller amid ongoing problems with medicine supplies and limited availability of certain drugs."
"The latest shortages include a disruption to the supply of Diclac a non-­steroidal anti-inflammatory drug used to relieve pain and inflammation."
General practitioners are reporting a shortage of Diclac tablets as demand increases unexpectedly, contributing to ongoing problems with medicine supplies and limited availability of certain drugs. The supply disruption affects Diclac, a non‑steroidal anti-inflammatory drug used to relieve pain and inflammation, reducing patient access to this common painkiller. Pharmacies and clinicians face stock gaps and may need to identify and prescribe suitable alternative analgesics or adjust treatment plans. Supply-chain, manufacturing, and distribution pressures are implicated in the shortages. Patients currently taking Diclac should consult healthcare providers for alternatives and for guidance on managing pain safely.
Read at Independent
Unable to calculate read time
Collection
[
|
...
]